{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T02:44:03Z","timestamp":1784774643341,"version":"3.55.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T00:00:00Z","timestamp":1723075200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["practicalradonc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Practical Radiation Oncology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.prro.2024.05.009","type":"journal-article","created":{"date-parts":[[2024,7,9]],"date-time":"2024-07-09T00:58:36Z","timestamp":1720486716000},"page":"541-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation Therapy"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9589-4873","authenticated-orcid":false,"given":"Jennifer","family":"Le Gu\u00e9velou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Zilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovic","family":"Ferretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Beuzit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"De Hertogh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Palumbo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjory","family":"Jolicoeur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilles","family":"Crehange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talar","family":"Derashodian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renaud","family":"De Crevoisier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chapet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Terlizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Supiot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Salembier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sargos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.prro.2024.05.009_bib0001","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.eururo.2020.09.042","article-title":"EAU-EANM-ESTRO-ESUR-SIOG guidelines on prostate cancer\u20142020 update. Part 1: Screening, diagnosis, and local treatment with curative intent","volume":"79","author":"Mottet","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2024.05.009_bib0002","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1111\/iju.14011","article-title":"Current status of intensity-modulated radiation therapy for prostate cancer: History, clinical results and future directions","volume":"26","author":"Hatano","year":"2019","journal-title":"Int J Urol"},{"key":"10.1016\/j.prro.2024.05.009_bib0003","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.clon.2012.05.002","article-title":"Intensity-modulated radiation therapy in the treatment of prostate cancer","volume":"24","author":"Bauman","year":"2012","journal-title":"Clin Oncol R Coll Radiol. G B"},{"key":"10.1016\/j.prro.2024.05.009_bib0004","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.canrad.2010.06.013","article-title":"Apports de la radioth\u00e9rapie avec modulation d'intensit\u00e9 guid\u00e9e par l'image dans les cancers prostatiques [Benefit of intensity modulated and image-guided radiotherapy in prostate cancer]","volume":"14","author":"Latorzeff","year":"2010","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.prro.2024.05.009_bib0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41391-022-00535-4","article-title":"Prostate cancer intensity-modulated radiation therapy and long term genitourinary toxicity: An evolving therapeutic landscape","volume":"26","author":"Achard","year":"2023","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"10.1016\/j.prro.2024.05.009_bib0006","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.eururo.2019.10.008","article-title":"Local failure and survival after definitive radiation therapy for aggressive prostate cancer: An individual patient-level meta-analysis of six randomized trials","volume":"77","author":"Kishan","year":"2020","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2024.05.009_bib0007","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2024.42.4_suppl.LBA259","article-title":"Long-term results of dose escalation (80 vs 70 Gy) combined with long-term androgen deprivation in high-risk prostate cancers: GETUG-AFU 18 randomized trial","volume":"42","author":"Hennequin","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0008","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1200\/JCO.20.02873","article-title":"Focal boost to the intraprostatic tumor in external beam radiation therapy for patients with localized prostate cancer: Results from the FLAME randomized phase III trial","volume":"39","author":"Kerkmeijer","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0009","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/S1470-2045(22)00517-4","article-title":"Intensity-modulated radiation therapy versus stereotactic body radiation therapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial","volume":"23","author":"Tree","year":"2022","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0010","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.ijrobp.2021.10.137","article-title":"SABR for high-risk prostate cancer: A prospective multilevel MRI-based dose escalation trial","volume":"113","author":"Hannan","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0011","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.3390\/cancers14143484","article-title":"A prospective study of stereotactic body radiation therapy (SBRT) with concomitant whole-pelvic radiation therapy (WPRT) for high-risk localized prostate cancer patients using 1.5 tesla magnetic resonance guidance: The preliminary clinical outcome","volume":"14","author":"Poon","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.prro.2024.05.009_bib0012","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.ijrobp.2023.02.054","article-title":"A randomized feasibility trial of stereotactic prostate radiation therapy with or without elective nodal irradiation in high-risk localized prostate cancer (SPORT Trial)","volume":"17","author":"Houlihan","year":"2023","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0013","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.euo.2023.01.009","article-title":"The safety and efficacy of salvage stereotactic radiation therapy in patients with intraprostatic tumor recurrence after previous external radiation therapy: Phase 1 results from the GETUG-AFU 31 study","volume":"6","author":"Pasquier","year":"2023","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0014","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.canrad.2021.11.017","article-title":"External radiation therapy for prostatic cancers","volume":"26","author":"de Crevoisier","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.prro.2024.05.009_bib0015","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.ijrobp.2019.11.005","article-title":"Stereotactic body radiation therapy to the prostate bed: Results of a phase 1 dose-escalation trial","volume":"106","author":"Sampath","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0016","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/j.ejmp.2016.08.013","article-title":"Bladder spatial-dose descriptors correlate with acute urinary toxicity after radiation therapy for prostate cancer","volume":"32","author":"Improta","year":"2016","journal-title":"Phys Med"},{"key":"10.1016\/j.prro.2024.05.009_bib0017","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.ijrobp.2013.10.042","article-title":"Impact of dose to the bladder trigone on long-term urinary function after high-dose intensity modulated radiation therapy for localized prostate cancer","volume":"88","author":"Ghadjar","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0018","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/mp.16878","article-title":"Dosimetric predictors for genitourinary toxicity in MR-guided stereotactic body radiation therapy (SBRT): Substructure with fraction-wise analysis","volume":"51","author":"Pham","year":"2024","journal-title":"Med Phys"},{"key":"10.1016\/j.prro.2024.05.009_bib0019","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.radonc.2021.12.027","article-title":"Urethral and bladder dose-effect relations for late genitourinary toxicity following external beam radiation therapy for prostate cancer in the FLAME trial","volume":"167","author":"Groen","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0020","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ijrobp.2022.01.022","article-title":"Intraprostatic urethra: the new kid on the block for prostate cancer radiation therapy?","volume":"113","author":"Zilli","year":"2022","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0021","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ijrobp.2021.06.037","article-title":"Radiation dose to the intraprostatic urethra correlates strongly with urinary toxicity after prostate stereotactic body radiation therapy: A combined analysis of 23 prospective clinical trials","volume":"112","author":"Leeman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.009_bib0022","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0360-3016(91)90055-9","article-title":"Definitive radiation therapy for localized prostatic adenocarcinoma","volume":"20","author":"Arcangeli","year":"1991","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.009_bib0023","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.tipsro.2021.05.003","article-title":"A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients","volume":"19","author":"Muggeo-Bertin","year":"2021","journal-title":"Tech Innov Patient Support Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0024","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/bju.14516","article-title":"Current management of radiation cystitis: a review and practical guide to clinical management","volume":"123","author":"Pascoe","year":"2019","journal-title":"BJU Int"},{"key":"10.1016\/j.prro.2024.05.009_bib0025","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/1520-6777(2000)19:5<585::AID-NAU5>3.0.CO;2-U","article-title":"Bladder wall thickness in normal adults and men with mild lower urinary tract symptoms and benign prostatic enlargement","volume":"19","author":"Hakenberg","year":"2000","journal-title":"Neurourol Urodyn"},{"key":"10.1016\/j.prro.2024.05.009_bib0026","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.ijrobp.2020.07.019","article-title":"Rectal and urethro-vesical subregions for toxicity prediction after prostate cancer radiation therapy: validation of voxel-based models in an independent population","volume":"108","author":"Mylona","year":"2020","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0027","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1001\/jamaoncol.2021.0039","article-title":"Safety and efficacy of virtual prostatectomy with single-dose radiation therapy in patients with intermediate-risk prostate cancer: Results from the PROSINT phase 2 randomized clinical trial","volume":"7","author":"Greco","year":"2021","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0028","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0197757","article-title":"Development of a prediction model for late urinary incontinence, hematuria, pain and voiding frequency among irradiated prostate cancer patients","volume":"13","author":"Schaake","year":"2018","journal-title":"PloS One"},{"key":"10.1016\/j.prro.2024.05.009_bib0030","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.ijrobp.2014.06.031","article-title":"Dose to the bladder neck is the most important predictor for acute and late toxicity after low-dose-rate prostate brachytherapy: Implications for establishing new dose constraints for treatment planning","volume":"90","author":"Hathout","year":"2014","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0031","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.brachy.2019.02.003","article-title":"Dose to the bladder neck in MRI-guided high-dose-rate prostate brachytherapy: Impact on acute urinary toxicity and health-related quality of life","volume":"18","author":"Sanmamed","year":"2019","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2024.05.009_bib0032","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/j.ijrobp.2010.11.054","article-title":"Long-term outcomes from a prospective trial of stereotactic body radiation therapy for low-risk prostate cancer","volume":"82","author":"King","year":"2012","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0033","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1001\/jama.296.19.2329","article-title":"Adjuvant radiation therapy for pathologically advanced prostate cancer: a randomized clinical trial","volume":"296","author":"Thompson","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/j.prro.2024.05.009_bib0034","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.brachy.2015.04.004","article-title":"High-dose-rate brachytherapy boost for prostate cancer: Outcomes and genitourinary toxicity","volume":"14","author":"Bece","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2024.05.009_bib0035","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.brachy.2012.03.004","article-title":"Urethral strictures following high-dose-rate brachytherapy for prostate cancer: Analysis of risk factors","volume":"12","author":"Hindson","year":"2013","journal-title":"Brachytherapy"},{"key":"10.1016\/j.prro.2024.05.009_bib0036","doi-asserted-by":"crossref","first-page":"3287","DOI":"10.1007\/s00345-023-04579-6","article-title":"State of the art and future challenges of urethra-sparing stereotactic body radiation therapy for prostate cancer: a systematic review of literature","volume":"41","author":"Le Guevelou","year":"2023","journal-title":"World J Urol"},{"key":"10.1016\/j.prro.2024.05.009_bib0037","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.ijrobp.2023.03.057","article-title":"Every-other-day versus once-a-week urethra-sparing prostate stereotactic body radiation therapy: 5-Year results of a randomized phase 2 trial","volume":"117","author":"Zilli","year":"2023","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.009_bib0038","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.radonc.2004.09.004","article-title":"GEC\/ESTRO-EAU recommendations on temporary brachytherapy using stepping sources for localised prostate cancer","volume":"74","author":"Kov\u00e1cs","year":"2005","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0039","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1186\/s13014-019-1424-8","article-title":"The urethral position may shift because of urethral catheter placement in the treatment planning for prostate radiation therapy","volume":"14","author":"Dekura","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0040","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.ijrobp.2019.08.007","article-title":"A prospective single-arm phase 2 study of stereotactic magnetic resonance guided adaptive radiation therapy for prostate cancer: Early toxicity results","volume":"105","author":"Bruynzeel","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0041","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.ijrobp.2018.09.023","article-title":"50-Gy Stereotactic body radiation therapy to the dominant intraprostatic nodule: Results from a phase 1a\/b trial","volume":"103","author":"Herrera","year":"2019","journal-title":"Int J Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0042","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ijrobp.2010.10.009","article-title":"Comparison of acute and late toxicities for three modern high-dose radiation treatment techniques for localized prostate cancer","volume":"82","author":"Mohammed","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.009_bib0043","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0360-3016(01)01811-9","article-title":"The dosimetry of prostate brachytherapy-induced urethral strictures","volume":"52","author":"Merrick","year":"2002","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.prro.2024.05.009_bib0044","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.radonc.2014.10.007","article-title":"Dosimetric analysis of urethral strictures following HDR 192Ir brachytherapy as monotherapy for intermediate- and high-risk prostate cancer","volume":"113","author":"D\u00edez","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0029","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.eururo.2021.05.022","article-title":"European Association of Urology Guidelines on urethral stricture disease (Part 1): Management of male urethral stricture disease","volume":"80","author":"Lumen","year":"2021","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2024.05.009_bib0045","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.eururo.2013.03.004","article-title":"EAU guidelines on the treatment and follow-up of non-neurogenic male lower urinary tract symptoms including benign prostatic obstruction","volume":"64","author":"Oelke","year":"2013","journal-title":"Eur Urol"},{"key":"10.1016\/j.prro.2024.05.009_bib0046","doi-asserted-by":"crossref","first-page":"555","DOI":"10.3389\/fonc.2020.00555","article-title":"Urinary morbidity in men treated with stereotactic body radiation therapy (SBRT) for localized prostate cancer following transurethral resection of the prostate (TURP)","volume":"10","author":"Pepin","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0047","doi-asserted-by":"crossref","first-page":"e392","DOI":"10.1016\/j.clon.2022.05.021","article-title":"Surgical treatments of benign prostatic hyperplasia and prostate cancer stereotactic radiation therapy: impact on long-term genitourinary toxicity","volume":"34","author":"Huck","year":"2022","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"10.1016\/j.prro.2024.05.009_bib0048","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.prro.2019.04.003","article-title":"Safety of prostate stereotactic body radiation therapy after transurethral resection of prostate (TURP): A propensity score matched pair analysis","volume":"9","author":"Murthy","year":"2019","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.prro.2024.05.009_bib0049","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2022.103661","article-title":"Highly hypofractionated schedules for localized prostate cancer: Recommendations of the GETUG radiation oncology group","volume":"173","author":"Lapierre","year":"2022","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.prro.2024.05.009_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.5114\/jcb.2013.36174","article-title":"Prospective multi-center dosimetry study of low-dose Iodine-125 prostate brachytherapy performed after transurethral resection","volume":"5","author":"Salembier","year":"2013","journal-title":"J Contemp Brachytherapy"}],"container-title":["Practical Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1879850024001450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:32:17Z","timestamp":1746189137000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1879850024001450"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":50,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1879850024001450"],"URL":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.009","relation":{},"ISSN":["1879-8500"],"issn-type":[{"value":"1879-8500","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urinary Organs at Risk for Prostate Cancer External Beam Radiation Therapy: Contouring Guidelines on Behalf of the Francophone Group of Urological Radiation Therapy","name":"articletitle","label":"Article Title"},{"value":"Practical Radiation Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prro.2024.05.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of American Society for Radiation Oncology.","name":"copyright","label":"Copyright"}]}}